Archives
-
o2h Ventures Recognised at EISA Impact Awards 2025 for Exonate’s Topical Eye-Drop for Diabetic Retinopathy 20 June, 2025
-
o2h Ventures Shortlisted for Two EISA Awards 2025: Impact and Ecosystem Champion 31 May, 2025
-
o2h Ventures Makes SEIS investment in Sansanima, A University of Sheffield Spinout Developing Alternatives to Animal Testing 28 May, 2025
-
o2h Ventures Shortlisted for ‘Seed VC of the Year’ at UKBAA Angel Investment Awards 2025 14 May, 2025
-
o2h Ventures Backs Enedra Therapeutics, Targeting Complex Cancers 07 May, 2025
-
o2h Ventures Makes a Follow-on Investment in Qkine, the Cambridge-based Specialist in Growth Factor Manufacturing 21 March, 2025
-
o2h Ventures Investment Spotlight – Revolutionising Prostate Cancer Treatment 30 January, 2025
-
o2h Ventures Makes an Investment in Atelerix, an Innovative Gel-Based Tech to Preserve Live Cells 29 January, 2025
-
o2h Ventures Invests in Revolver Therapeutics Revolutionising Childhood Cancer Treatment 10 December, 2024
invest in the growth potential of UK life science & AI